Renaissance Technologies (RenTech)'s BCDA Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 13,900 shares of BioCardia, Inc. (BCDA) worth $16,819, representing 0.00% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in BCDA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 13,900 shares. Largest reduction occurred in Q2 2021, reducing 13,532 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s BioCardia (BCDA) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioCardia (BCDA) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +13,900 | New Buy | 13,900 | $1.21 |
| Q1 2024 | -5,887 | Sold Out | 0 | $0.00 |
| Q4 2023 | +5,187 | Add 741.00% | 5,887 | $10.02 |
| Q3 2023 | -480 | Reduce 40.68% | 700 | $7.14 |
| Q2 2023 | +140 | Add 13.46% | 1,180 | $0.04 |
| Q1 2023 | +100 | Add 10.64% | 1,040 | $0.03 |
| Q4 2022 | -13 | Reduce 1.36% | 940 | $0.03 |
| Q3 2022 | -34 | Reduce 3.44% | 953 | $29.38 |
| Q2 2022 | +74 | Add 8.11% | 987 | $21.28 |
| Q1 2022 | +913 | New Buy | 913 | $30.67 |
| Q4 2021 | -2,903 | Sold Out | 0 | $0.00 |
| Q3 2021 | -3,912 | Reduce 57.40% | 2,903 | $47.19 |
| Q2 2021 | -13,532 | Reduce 66.51% | 6,815 | $59.57 |
| Q1 2021 | +20,347 | New Buy | 20,347 | $65.12 |
Renaissance Technologies (RenTech)'s BioCardia Investment FAQs
Renaissance Technologies (RenTech) first purchased BioCardia, Inc. (BCDA) in Q1 2021, acquiring 20,347 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held BioCardia, Inc. (BCDA) for 14 quarters since Q1 2021.
Renaissance Technologies (RenTech)'s largest addition to BioCardia, Inc. (BCDA) was in Q1 2021, adding 20,347 shares worth $1.32 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 13,900 shares of BioCardia, Inc. (BCDA), valued at approximately $16,819.
As of the Q1 2026 filing, BioCardia, Inc. (BCDA) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in BioCardia, Inc. (BCDA) was 20,347 shares, as reported at the end of Q1 2021.